Tag Archives: united kingdom

U.K. agency recommends Sucampo drug

Sucampo Pharmaceuticals Inc.,  of Bethesda, a global biopharmaceutical company, announced that the United Kingdom’s National Institute of Health and Care Excellence has issued a guidance recommending the use of Sucampo’s Amitiza (lubiprostone) in the treatment of chronic idiopathic constipation and ...

Read More »